$TMUS Buy? Hold? Sell? Overall Average: 96% Buy Sunday, November

A New Era for Pickleball in Palm Beach It might be time to re-evaluate pickleball if you weren't paying attention before. The Palm Beach Royals have wrapped up their first Major League Pickleball season with a bang, marking a pivotal year for the sport. This underdog tale of graft and grit is carving out a new chapter in the world of sport. Record-Breaking Season for MLP...

Co-op Living: Not All It's Cracked Up to Be Let me tell you something, buying a co-op in New York City isn't just signing on the dotted line and moving in. Nope, it's a whole damn production. Jeff Namian's book, Thin Walls/Thick Ears, lays it all out with a mix of humor and hard truths, painting a stark picture of NYC co-op living. He's not just telling his own story of...

Facing the Realities of Aging In Place Alright, let's talk straight. Everyone dreams of staying home in their twilight years, kicking back in their favorite chair with family nearby. But the harsh truth? That comfort comes with a price tag. According to Northwestern Mutual's 2026 Planning & Progress Study, up to 83% of Boomers+ and most other generations fancy the idea of...

Getting Ahead of the Travel Expense Game Rising fees and tighter budgets haven't persuaded holiday travelers to abandon their plans. Instead, they’re sharpening their axes, looking for clearer paths to their vacation goals without slicing off an arm and a leg. With the cost of travel climbing faster than a runaway elevator, folks are getting smart about where their...

TRIMAX's Bold Move into AI-Powered Infrastructure It feels like we're standing on the cusp of a seismic shift, folks. Artificial intelligence isn't just another buzzword anymore—it's a juggernaut reshaping our digital world. TRIMAX Power Systems is gearing up to ride this wave, with its eyes set on capturing a chunk of the booming demand for fast-deployable power...

Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...

Turning the Insurance World on Its Head Just when you think the enterprise software scene is getting predictable, along comes a bit of news to shake things up. Guidewire, a name known in the P&C insurance software world, has roped in a veteran—Dan Brown—who's got more than a quarter-century under his belt shaping product strategies. It’s not just another suit...

Revolutionizing Cookware: The Launch of Hybrid 2.0 Today, everyone's buzzing about ProClad's big reveal—the Hybrid 2.0 Pan. Now, before you roll those skeptical eyes, hear me out. This isn’t your average bit of kitchen fluff; it’s a heavyweight contender stepping into the everyday cooking ring. What they've done here is combine the muscle of stainless steel searing...

The Dawn of On-Chain Machine Learning In a world where crypto folks often tout decentralization like it’s the holy grail, GenesisL1 is throwing open the doors to a new kind of crypto playground with GL1F Crypto. A decentralized on-chain AI studio? Sounds like sci-fi, but here we are—hands on the precipice of democratized machine learning in your browser. A Lab in...

Diving into Barnegat's Dermatology Landscape Metropolitan Dermatology has taken a strategic step by opening a new location right in the heart of Barnegat, New Jersey. Talk about a win-win for the folks in Ocean County. This isn't just another clinic opening up shop; it's about bringing comprehensive medical and surgical dermatologic care straight to the people who need...

New Leadership at The Armstrong Company It’s about time. Armstrong’s rolling out fresh faces in the top spots. Todd Watson’s stepping down as CEO, but don’t get it twisted—he’s not leaving the building; he’s now co-chair along with his cousin Mark Pickens. These guys are the latest entries in a long line of leadership dating back to their founders in 1957....

NVIDIA's Upcoming Conference Call for Financial Results NVIDIA is gearing up to connect with stakeholders through a conference call planned for a future date. This call will focus on discussing the financial results for the company's third quarter of the current fiscal year. Investors and analysts will have the opportunity to gain insights into the financial landscape of...

Free Heart and Kidney Health Screenings in Seattle Residents of Seattle have a valuable opportunity coming up with the Heart & Kidney Health Screening initiative offered by Care Access. This program aims to enhance awareness of crucial health risk factors, particularly the dangerous lipoprotein(a), often abbreviated as Lp(a). Affecting one in five individuals, high Lp(a)...

Protect Your Investment with Legal Guidance In the fast-paced world of investing, timely information is crucial for making informed decisions. This is especially true for investors in Replimune Group, Inc. (NASDAQ: REPL) who have participated in transactions within recent class periods. Understanding your rights and options can significantly affect your financial future....

Important Opportunity for Kyverna Therapeutics, Inc. Investors Kyverna Therapeutics, Inc. (NASDAQ: KYTX) provides a significant opportunity for its shareholders due to a potential class action lawsuit concerning possible securities fraud. If you're someone who purchased common stock during the company’s initial public offering (IPO), you might be entitled to...